AKT1 and ovarian carcinoma: Through its regulatory effects on the PI3K/AKT signaling cascade, melatonin enhances programmed cell death in ovarian carcinoma cells, thereby suppressing tumor progression and malignant transformation (Baghal-Sadriforoush et al., 2022).